Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V On Drugs With The Active Ingredient Infliximab (l04ab02) As Part Of A So-called Open-house Model.
Contract pursuant to Section 127 para. 1 SGB V for the supply of insured persons of the AOK Rhineland-Palatinate/Saarland with breast prostheses of product group 37